NovaBridge Biosciences (NBP) Financials: Revenue & Earnings

NBP price $1.23 -0.03 -1.99%

Ticker
NBP
Price
$1.23
Change
-0.03 -1.99%
Market cap ?
$141.78M
Beta ?
1.60
Sector
Healthcare
Industry
Biotechnology

Fair value

NBP fair value $269.74. Price $1.23. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare NBP

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-31—-0.03—17.49M
2026-11-12—-0.08—33.59M
2026-08-20-0.02-0.03——
2026-07-30-0.22-0.01——
2025-12-18-0.03-0.06——
2025-08-26-0.03-0.06——
2025-05-15-0.02-0.06——
2025-03-31-0.06-0.06—1.50M
2024-11-14-0.25-0.16—1.50M
2024-08-28-0.07-0.519.86M1.50M
2024-06-05-0.03———
2024-03-14-0.40-0.691.18M7.00M
2023-08-17-0.56-0.262.70M7.00M
2023-04-04-1.29—46.55M—
2023-03-31-0.68-0.491.43M—
2022-08-30-0.83-1.117.74M17.50M
2022-03-29-1.17-0.3411.02M77.00M
2021-11-12-1.24—5.44M—
2021-08-31-0.99-0.362.77M33.60M
2021-03-290.850.91238.55M134.03M
2020-08-31-0.68-0.53——
2020-03-31-16.47———
2020-01-17-0.95—11.11K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15Woo Ian YingBuy13.27K——
2026-10-15Woo Ian YingSell5.77K——
2026-09-18Dennis Phillip AndrewSell8.21K$0.715.83K
2026-09-17Dennis Phillip AndrewBuy23.70K——
2026-09-17Dennis Phillip AndrewSell10.30K——
2026-09-09Cao Sean WuxiongSell107.98K$0.7479.90K
2026-09-08Dewhurst Martin WilliamOther0——
2026-09-03Cao Sean WuxiongBuy104.24K——
2026-09-03Cao Sean WuxiongSell102.23K——
2026-09-03Cao Sean WuxiongBuy235.14K——
2026-09-03Cao Sean WuxiongSell45.32K——
2026-08-31Xu Cong ClaireSell3.28K$0.792.59K
2026-08-30Xu Cong ClaireBuy9.38K——
2026-08-30Xu Cong ClaireSell4.08K——
2026-08-22Lenz Robert A.Buy17.22K——
2026-08-22Lenz Robert A.Sell7.49K——
2026-07-08Hagler Mark ArnoldBuy949.05K$1.931.83M
2026-07-08Lin Liwei LorraineBuy254.78K$1.93491.73K
2026-07-06Gupta SrishtiBuy3.00M$2.016.03M
2026-07-06Xu Cong ClaireSell4.49K$0.893.99K
2026-07-04Xu Cong ClaireBuy12.43K——
2026-07-04Xu Cong ClaireSell5.41K——
2026-07-01Gupta SrishtiOther0——
2026-06-29Fu WeiBuy1.09M$2.452.66M
2026-06-29Fu WeiBuy1.01M——
2026-06-29Fu WeiBuy725.14K$2.451.78M
2026-06-22Cao Sean WuxiongBuy181.29K$1.53277.37K
2026-06-22Cao Sean WuxiongBuy181.28K——
2026-06-18Dennis Phillip AndrewSell8.49K$0.665.61K
2026-06-17Dennis Phillip AndrewBuy23.70K——
2026-06-17Dennis Phillip AndrewSell10.30K——
2026-06-01Xu Cong ClaireSell3.49K$3.9413.77K
2026-05-30Xu Cong ClaireBuy9.38K——
2026-05-30Xu Cong ClaireSell4.08K——
2026-05-14Cao Sean WuxiongSell21.40K$1.9942.58K
2026-04-24Hagler Mark ArnoldBuy230.00K$2.51577.30K
2026-04-17Hagler Mark ArnoldOther0——
2026-03-18Xu Cong ClaireOther0——
2026-03-18Yang Conor Chia-hungOther114.09K$1.22139.19K
2026-03-18Yang Conor Chia-hungOther34.53K$3.86133.29K
2026-03-18Chu Denny Hsueh WenOther0——
2026-03-18Dennis Phillip AndrewOther0——
2026-03-18Dennis Phillip AndrewOther494.51K$1.82900.01K
2026-03-18Dennis Phillip AndrewOther186.30K$1.05195.62K
2026-03-18Dennis Phillip AndrewOther92.72K——
2026-03-18Lin Liwei LorraineOther0——
2026-03-18Fu Xi-YongOther0——
2026-03-18Fu Xi-YongOther1.25M$1.071.33M
2026-03-18Fu Xi-YongOther1.25M——
2026-03-18Zhang Xiaofan NeoOther0——
2026-03-18Lei Ming KylerOther996.77K$4.254.24M
2026-03-18Wu Joanna XuqiongOther0——
2026-03-18Wu Joanna XuqiongOther0——
2026-03-18Wu Joanna XuqiongOther46.88K$3.31155.16K
2026-03-18Wu Joanna XuqiongOther24.17K——
2026-03-18Fu WeiOther0——
2026-03-18Fu WeiOther0——
2026-03-18Fu WeiOther0——
2026-03-18Fu WeiOther0——
2026-03-18Fu WeiOther0——
2026-03-18Fu WeiOther2.45M$3.197.83M
2026-03-18Cao Sean WuxiongOther0——
2026-03-18Cao Sean WuxiongOther19.37K$1.1722.66K
2026-03-18Cao Sean WuxiongOther408.93K$4.651.90M
2026-03-18Cao Sean WuxiongOther408.93K——
2026-03-18Cunningham EmmettOther120.00K$3.21385.20K
2026-03-18Xu Cong ClaireOther0——
2026-03-18Xu Cong ClaireOther22.90K$60.701.39M
2026-03-18Xu Cong ClaireOther43.69K$21.15924.04K
2026-03-18Xu Cong ClaireOther57.66K$5.55320.01K
2026-03-18Xu Cong ClaireOther146.87K$1.74255.55K
2026-03-18Xu Cong ClaireOther52.16K$1.0554.77K
2026-03-18Xu Cong ClaireOther5.41K——
2026-03-18Liu XinOther0——
2026-03-18Zhang Adeline YiOther0——
2026-03-18Woo Ian YingOther15.85K$6.1397.16K
2026-03-18Woo Ian YingOther17.31K——
2026-03-18Lenz Robert A.Other19.13K$5.0997.37K
2026-03-18Lenz Robert A.Other22.46K——
2026-03-18Au Chun Kwok AlanOther114.09K$1.22139.19K
2026-03-18Au Chun Kwok AlanOther34.53K$3.86133.29K

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

NovaBridge Biosciences (NBP) trades at $1.23, with a market cap of $141.78M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

NovaBridge Biosciences (NBP) Financials: Revenue & Earnings

NBP$1.23-0.03 -1.99%

$141.78M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History